According to Goldstein Research, global anticoagulation therapy market is expected to reach USD 31.4 billion by 2025, expanding at a CAGR of 8.01% over the forecast period, 2017-2025.

Increasing number of patients with lifelong medical aid therapy, growing prevalence of blood vessel thromboembolism, rising outpatient anticoagulation therapy and rising heparin trade is spurring the growth of the market.

Global anticoagulation therapy market segmentation has been done on the basis of product type, by clinic and geography. The NOACs segment led the anticoagulation therapy market for drugs in 2017 owing to the emergence of many pharma companies to develop more secure and structured NOAC’s in future years, growing at a CAGR of 7.88% among the PT/INR testing devices.

Global Anticoagulation therapy market is dominated by North America owing to rising number of the hospital associated clinics and high healthcare expenditure. Europe is expected to grow at the higher rate and generate quite the substantial amount of revenue owing to rising incidence of venous thromboembolism, atrial fibrillation, and stroke.

Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/global-anticoagulation-therapy-market

Market Segmentation

On the basis of our in-depth analysis, Global Anticoagulation Therapy Market can be segmented as follows:

By Product Type

o Drugs

· Novel Oral Anticoagulants (NOACs)

· Warfarin (VKA)

· Other Drugs

o PT/INR Testing Devices

· In-Office Testing Devices

· Analyzers

· Agents and Kits

· Home Testing Devices

Service

· Testing Services

· Consulting Services

By Clinic

o Hospital Associated Clinic

o Independent Clinics

o Pharmacy-based Clinics

By Region

o North America (U.S. & Canada) Anticoagulation therapy Market {Market Share (%), Market Size (USD Billion)}

o Latin America (Brazil, Mexico, Argentina & Rest of Latin America) Anticoagulation therapy Market {Market Share (%), Market Size (USD Billion)}

o Europe (The U.K., Germany, France, Italy, Hungary, Spain, Poland, Sweden & RoE) Anticoagulation therapy Market {Market Share (%), Market Size (USD Billion)}

o Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) Anticoagulation therapy Market {Market Share (%), Market Size (USD Billion)}

o Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Anticoagulation therapy Market {Market Share (%), Market Size (USD Billion)}

Browse Full Report: https://www.goldsteinresearch.com/report/global-anticoagulation-therapy-market

“Global Anticoagulation Therapy Market Outlook 2024” contains the detailed overview of the Global Anticoagulation therapy market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by product type and clinic.

Further, for the in-depth analysis, Global Anticoagulation Therapy Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.

This market report also includes competitive outlook of some of the major players profiling of companies such as C. H. Boehringer Sohn, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, Daiichi Sankyo, Portola Pharmaceuticals, Roche, Abbott, Siemens, Alere, and CoaguSense, etc.

The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services, and industries catered, financial analysis of the company and recent developments.

Overall, the report represents the Global Anticoagulation therapy market trends along with the market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Global, Asia, and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts.

Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.

Our analysts working on healthcare industry analysis reports helping various tech-giants, tech start-ups, and entry players to assess the current and upcoming business scenario. We believe in the rigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable for our clients’ needs and business agenda.

Contact for more Info:

Steve Blade

(Global Sales Head)

USA: + 1-646-568-7747

Canada: 1-437-886-1181

UK: +44-203-318-6627

[email protected]

www.goldsteinresearch.com

Browse Similar Report: Global Plasma Protein Therapeutics Market